Market Performance of iRadimed Corp. (IRMD)
iRadimed Corp. (ticker IRMD) increased by 0.67 % during the 24‑hour period ending at 12:08 PM Central Europe on Wednesday, 21 March 2026. The current trading price on major exchanges is USD 88.24.
Trading Metrics
- Shares Outstanding: 12.8 million
- Market Capitalization: USD 1.1 billion
- 24‑Hour Volume: USD 7.3 million
Since the end of the previous month, the share price has risen 7.01 %. The 200‑day simple moving average is USD 93.12.
52‑Week Price Range
- High: USD 107.90 (10 Feb 2026)
- Low: USD 75.75 (30 Oct 2025)
Comparison with Peer Companies (24‑Hour Performance)
| Company | Ticker | 24‑Hour Change | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|---|
| Arlo | ARLO | +2.20 % | USD 12.52 | USD 1.3 billion | 43.91 |
| Rex American | REX | +0.20 % | USD 40.53 | USD 1.3 billion | 11.1 |
| Oric | ORIC | +8.33 % | USD 13.78 | USD 1.3 billion | – |
| Inhibrx Biosciences | INBX | +6.14 % | USD 95.3 | USD 1.3 billion | – |
| Tyra Biosciences | TYRA | +5.84 % | USD 20.47 | USD 1.3 billion | – |
Company Overview
iRadimed Corp., headquartered in Winter Springs, Florida, United States, specializes in the manufacture and distribution of non‑magnetic intravenous infusion pump systems designed for use during magnetic resonance imaging (MRI) procedures. The company operates within the healthcare equipment and supplies sector.
